Back
15.
August
2017.
Innovative MediSieve blood filter shortlisted for prestigious TCT Awards 2017
Innovative MediSieve blood filter shortlisted
for prestigious TCT Awards 2017
The team behind the medical device start-up
MediSieve have been nominated for their potentially life-saving magnetic blood
filtration device in the Healthcare Application category of the TCT Magazine
2017 Awards.
MediSieve was nominated for the award thanks to
its novel approach to a huge public health issue. The device is an easily
applied magnetic sieve which allows for easier treatment of the global killer
malaria by directly filtering infected cells from a patient’s bloodstream.
As the device concludes pre-clinical validation
and progresses to clinical trials, MediSieve’s experts are now beginning
research into ways to broaden the applications of their device, using magnetic
particles to target specific disease-causing components in blood. This could
include treatments for sepsis and leukaemia.
The TCT Awards judges will look at the
category’s contenders and consider how they capitalise on 3D technologies, in
particular, the ability to create bespoke one-off parts. They will also look at
how they could save lives, whether they reduce costs for healthcare providers
and how novel they are. The last criteria are their prospects for future
development and their social and educational impact.
George Frodsham, founder and CEO of MediSieve,
said: “3D printing had been an invaluable tool for us, particularly when we
needed to frequently change small physical aspects of our design. Our Rep Rap
3D printer enabled us to do this easily, quickly and cheaply. I don't know how
we would have managed otherwise - it would have been difficult to survive as a
start up on a very tight budget.”
The annual TCT Awards cover ten categories and
celebrate innovation and collaboration across the R&D sector. Projects
which see designers and engineers are of particular interest. The Awards show
will be held in September.
The nomination is the latest achievement for the
MediSieve team which has already reached the final round of MassChallenge UK
2016, a global non-profit startup accelerator. The team has also enjoyed
£350,000 in seed funding from angel investors, received a Pathfinder Award from
the Wellcome Trust, won an Innovate UK Smart 2015/16 Proof of Concept Award
grant worth £100,000 and secured €50,000 of funding through the EU Horizon 2020
programme.
The team behind the device have also presented
at the Royal Society of Medicine's 12th Medical Innovations Summit and been
featured in The Telegraph and many other major journals and publications.